Letter by Abdellaoui et al regarding article, "Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention".
Abdellaoui
Mohamed
M
Rioufol
Gilles
G
Finet
Gérard
G
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003331:Coronary Vessels / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab